Genetics of Parkinson's disease and biochemical studies of implicated gene products
- 14 June 2002
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 12 (3), 299-306
- https://doi.org/10.1016/s0959-437x(02)00302-7
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutationMovement Disorders, 2001
- Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's diseaseFEBS Letters, 2001
- Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's DiseaseBiochemistry, 2001
- Interaction of α‐synuclein and synphilin‐1: effect of Parkinson's disease‐associated mutationsJournal of Neurochemistry, 2001
- Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. WrightJournal of Molecular Biology, 2001
- The parkin gene and its phenotypeNeurological Sciences, 2001
- Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonismAnnals of Neurology, 2000
- Diverse Mutations in the Gene for Cartilage Oligomeric Matrix Protein in the Pseudoachondroplasia–Multiple Epiphyseal Dysplasia Disease SpectrumAmerican Journal of Human Genetics, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997